Literature DB >> 6133300

Profile of acute tolerance to three sedative anxiolytics.

E H Ellinwood, M Linnoila, M E Easler, D W Molter.   

Abstract

Acute tolerance, defined as a decreasing drug effect relative to drug-plasma levels (DPL) over a period of minutes to a few hours, is pronounced following single doses of diazepam or pentobarbital. Both of these lipid-soluble drugs produce an early peak behavioral impairment and subsequent rapid recovery component that is followed by a much slower blood-drug rise time. These pronounced early peak effects were not shared by alcohol, and contribute significantly to the lack of correlation between impairment and DPL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6133300     DOI: 10.1007/bf00427800

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  The fate of pentobarbital in man and dog and a method for its estimation in biological material.

Authors:  B B BRODIE; J J BURNS; L C MARK; P A LIEF; E BERNSTEIN; E M PAPPER
Journal:  J Pharmacol Exp Ther       Date:  1953-09       Impact factor: 4.030

2.  Rapid gas chromatographic assay of serum diazepam, N-desmethyldiazepam, and N-desalkylflurazepam.

Authors:  M Linnoila; F Dorrity
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1977-11

3.  Diazepam actions and plasma concentrations following ethanol ingestion.

Authors:  S M MacLeod; H G Giles; G Patzalek; J J Thiessen; E M Sellers
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

4.  The relationship between alcohol dosage and performance decrement in humans.

Authors:  H M Franks; V R Hensley; W J Hensley; G A Starmer; R K Teo
Journal:  J Stud Alcohol       Date:  1976-03

Review 5.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

6.  Interaction and acute cross tolerance between ethanol and hexobarbitone in the rat.

Authors:  G Wahlström; E Widerlöv
Journal:  J Pharm Pharmacol       Date:  1971-01       Impact factor: 3.765

7.  Effects of different rates of absorption of two benzodiazepins on subjective and objective parameters. Significance for clinical use and risk of abuse.

Authors:  A Bliding
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

8.  Analysis of growth and dose response curves.

Authors:  J E Grizzle; D M Allen
Journal:  Biometrics       Date:  1969-06       Impact factor: 2.571

9.  The permeability of brain capillaries to non-electrolytes.

Authors:  C Crone
Journal:  Acta Physiol Scand       Date:  1965-08

10.  Barbiturate receptor sites are coupled to benzodiazepine receptors.

Authors:  F Leeb-Lundberg; A Snowman; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  23 in total

1.  Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.

Authors:  A Cleton; D Mazee; R A Voskuyl; M Danhof
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.

Authors:  J W Mandema; E Tukker; M Danhof
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

3.  Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.

Authors:  V Gentil; S Tavares; C Gorenstein; C Bello; L Mathias; G Gronich; J Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines.

Authors:  J Ingum; R Bjørklund; A Bjørneboe; A S Christophersen; E Dahlin; J Mørland
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Objective and subjective assessments of the effects of flupentixol and benzodiazepines on human psychomotor performance.

Authors:  M J Mattila; M Mattila; K Aranko
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  A late-appearing benzodiazepine-induced hypoactivity that is not reversed by a receptor antagonist.

Authors:  R G Lister; S E File
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

7.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

8.  Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam.

Authors:  E H Ellinwood; D G Heatherly; A M Nikaido; T D Bjornsson; C Kilts
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

9.  Diazepam: prediction of pharmacodynamics from pharmacokinetics.

Authors:  E H Ellinwood; A Nikaido; D Heatherly
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats.

Authors:  A M Stijnen; I Postel-Westra; M W Langemeijer; A Hoogerkamp; R A Voskuyl; C F van Bezooijen; M Danhof
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.